Management of Non-Alcoholic Fatty Liver disease with Unani medicine: A Review

The prevalence of non-alcoholic fatty liver disease (NAFLD), a common chronic liver condition, is high in developed nations. One of the main contributors to chronic liver disease and cryptogenic cirrhosis has been identified as NAFLD. A greater risk of developing NAFLD exists in those with obesity, insulin resistance, diabetes mellitus, hyperlipidemia, and hypertension. The connected key pathological processes, such as insulin resistance, abnormal lipid metabolism, oxidative stress, inflammation, apoptosis, and fibrosis, are linked to the development of NAFLD. From basic steatosis to non-alcoholic steatohepatitis, NAFLD can evolve (NASH). For the treatment of NAFLD, the herbal medicine has had significant positive effects on the reduction of inflammation and steatosis. It has been discovered that these effects involved the various lipid metabolism and inflammatory regulation pathways. In this study, we focus particularly on the use of herbal medicine for treating fatty liver disease and provide an overview of the research on NAFLD, herbal medicine research, and the idea and function of unani medicine in treating fatty liver disease.